سعر ميكارديس 80مجم 28 اقراص 2024

Telmisartan 80 mg tablets, 28 tablets (4 strips) (Micardis, Boehringer Ingelheim).

• Treatment of essential hypertension.Population: Adultselectronic medicines compendium (eMC)
• Reduction of cardiovascular morbidity.Population: Adults with manifest atherothrombotic cardiovascular disease or type 2 diabetes with documented target organ damageelectronic medicines compendium (eMC)

• Serious but rare: anaphylactic reaction, angioedema; acute renal failure. Uncommon: urinary and upper respiratory infections, anaemia, hyperkalaemia, insomnia, depression, syncope, vertigo, bradycardia, hypotension, orthostatic hypotension, dyspnoea, cough, abdominal pain, diarrhoea, dyspepsia, flatulence, vomiting, pruritus, rash, hyperhidrosis, back pain, muscle spasms, myalgia, renal impairment, chest pain, asthenia, raised creatinine. Rare: sepsis, thrombocytopenia, hypoglycaemia in diabetics, hepatic function abnormal; very rare: interstitial lung disease.International label, same product · electronic medicines compendium (eMC)

• Hypersensitivity; second and third trimesters of pregnancy; biliary obstructive disorders; severe hepatic impairment; with aliskiren in patients with diabetes or renal impairment (GFR <60 ml/min/1.73 m2).International label, same product · electronic medicines compendium (eMC)

• Do not start during pregnancy; stop immediately when pregnancy is diagnosed and switch to an alternative where appropriate.International label, same product · electronic medicines compendium (eMC)
• Dual RAAS blockade (ACE inhibitor, ARB or aliskiren) increases hypotension, hyperkalaemia and renal impairment and is not recommended; ACE inhibitors and ARBs should not be combined in diabetic nephropathy.International label, same product · electronic medicines compendium (eMC)
• Risk of severe hypotension and renal insufficiency in bilateral renal artery stenosis; symptomatic hypotension in volume/sodium depletion (correct first); hyperkalaemia risk especially in elderly, renal insufficiency, diabetes and with potassium-raising drugs; caution in aortic/mitral stenosis and obstructive hypertrophic cardiomyopathy; hypoglycaemia may occur in diabetics on insulin or antidiabetics.International label, same product · electronic medicines compendium (eMC)

• DigoxinTelmisartan raised digoxin peak (49%) and trough (20%) levels; monitor digoxin when starting, adjusting or stopping telmisartan.electronic medicines compendium (eMC)
• Potassium-sparing diuretics, potassium supplements, potassium-containing salt substitutesSignificant rise in serum potassium; concomitant use not recommended (if needed, monitor potassium frequently).electronic medicines compendium (eMC)
• LithiumReversible increases in serum lithium and toxicity; monitor lithium levels if the combination is necessary.electronic medicines compendium (eMC)

• No information during breastfeeding; not recommended, alternatives preferred especially for newborn or preterm infants.International label, same product · electronic medicines compendium (eMC)

• Telmisartan: Selective AT1 antagonist blocking angiotensin II vasoconstriction and aldosterone secretion.